In non-controlled studies, where lamivudine was administered prior to and during transplantation, effective HBV DNA suppression and ALT normalisation was demonstrated.
In studi non contrôlati, che lamivudine è administrata a priori e durante la transplantazione, il suppressione delle ADN HBV e la normalizazione ALT.